Dr. Kavarian is the current Transplant Hepatology Fellow at Cincinnati Children's Hospital. She completed her Pediatric Residency at Children's Hospital Los Angeles and her Pediatric Gastroenterology Fellowship at Stanford University. Her clinical and research interests include metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitis, with a passion for improving outcomes and quality of life for children with liver disease.

Michael Trauner, MD, received his medical education at the Karl-Franzens-University in Graz, Austria, where he also completed his clinical training in internal medicine and gastroenterology / hepatology. From 1994 to 1997 he postdoctoral research fellow at Yale University's Department of Internal Medicine and Liver Center in New Haven, USA. After returning to Graz, he established an internationally recognized research group in cholestatic and fatty liver diseases, and founded the Liver Center, serving as professor of experimental and clinical hepatology from 2005-2010.

Silvia Vilarinho is a physician-scientist who investigates the genetic and molecular basis of liver diseases using genomics and human samples, having identified five novel genetic liver diseases. Her research aims to discover new genes important for liver function and to use cell biology and animal models to determine the specific mechanism(s) linking mutant gene to disease as a roadmap to further understand and treat rare and common liver diseases.

Fionna Kopp is the patient co-chair of A-LiNK (Autoimmune Liver Disease Network for Kids), where she collaborates with physicians, researchers, quality improvement experts, and patients and families to improve outcomes for children with AIH and PSC. She is a PhD student in Mechanical Engineering at the University of California, Berkeley.

Madelyn is a liver transplant recipient who was transplanted at Medstar Georgetown University Hospital and is a molecular biology and biotechnology student at George Mason University. One year after her transplant, Madelyn graduated from high school and was looking for a way to bring organ donation awareness to her college campus. She was introduced to Student Organ Donation Advocates (SODA) and started the first Virginia chapter at GMU. Since then, Madelyn has participated in advocacy work with other organizations.

Melissa Kochanowsky is the Associate Program Director at PFIC Network, a nonprofit supporting patients and families worldwide affected by progressive familial intrahepatic cholestasis (PFIC). She helps lead global PFIC-focused initiatives in education, support, and research, and serves as Principal Investigator for the PFIC Network Patient Registry. She also co-led Project IMPACT (Identifying research targets by Merging Patient And Clinician Treatment information), a PCORI-funded initiative to build capacity for patient-centered comparative clinical effectiveness research in PFIC.

Dr. Amy Taylor completed her medical training at Cincinnati Children's Hospital, where she then continued as an Assistant Professor. She currently serves as the Program Director for the Transplant Hepatology Fellowship. Her research focus is on patient-centered outcomes improvement in pediatric Autoimmune Liver Disease. She serves as the PI for A-LiNK: the Autoimmune Liver disease Network for Kids, a multi-center learning health network.

Emily Ventura, BSN, is the Co-founder and Executive Director of Progressive Familial Intrahepatic Cholestasis Advocacy and Resource Network. Established in 2018, PFIC Network's mission is to improve the lives of patients and families worldwide affected by PFIC. As the mother of a PFIC patient, she is deeply connected to this work. Prior to founding PFIC Network, Emily had a long career as an ICU nurse, which gives her unique insight into both the clinical and personal sides of the rare patient experience.

Originally from Beirut, Lebanon, Dr. Rima Fawaz received her undergraduate and medical degree at the American University of Beirut. She then completed her pediatric residency at Upstate Medical University in Syracuse, Gastroenterology fellowship at Montefiore Medical Center and her Pediatric Transplant Hepatology fellowship at Mount Sinai Hospital in New York City. Once she completed her training, Dr.

Andrew Wehrman is a pediatric transplant hepatologist at Boston Children's Hospital. He has research interests in cholestatic liver diseases including Alagille syndrome, biliary atresia, and progressive familial intrahepatic cholestasis.